BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10411554)

  • 21. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
    Gether U; Emonds-Alt X; Brelière JC; Fujii T; Hagiwara D; Pradier L; Garret C; Johansen TE; Schwartz TW
    Mol Pharmacol; 1994 Mar; 45(3):500-8. PubMed ID: 8145735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the binding sites of [3H]SR 48968, a potent nonpeptide radioligand antagonist of the neurokinin-2 receptor.
    Emonds-Alt X; Golliot F; Pointeau P; Le Fur G; Breliere JC
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1172-7. PubMed ID: 7682062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors.
    Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
    Biochem Biophys Res Commun; 2000 Apr; 270(2):668-72. PubMed ID: 10753681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nepadutant at tachykinin NK(2) receptors in human intestine and urinary bladder.
    Patacchini R; Giuliani S; Turini A; Navarra G; Maggi CA
    Eur J Pharmacol; 2000 Jun; 398(3):389-97. PubMed ID: 10862829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality.
    Warner FJ; Mack P; Comis A; Miller RC; Burcher E
    Biochem Pharmacol; 2001 Jan; 61(1):55-60. PubMed ID: 11137709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tachykinin effects on bladder activity in conscious normal rats.
    Ishizuka O; Mattiasson A; Andersson KE
    J Urol; 1995 Jul; 154(1):257-61. PubMed ID: 7539864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.
    Gembitsky DS; Murnin M; Otvös FL; Allen J; Murphy RF; Lovas S
    J Med Chem; 1999 Jul; 42(15):3004-7. PubMed ID: 10425111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of NK(2) tachykinin receptors to propulsion in the rabbit distal colon.
    Onori L; Aggio A; Taddei G; Tonini M
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G137-47. PubMed ID: 10644572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of tachykinin NK1 and NK2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs.
    Lecci A; Giuliani S; Tramontana M; Giorgio RD; Maggi CA
    Br J Pharmacol; 1998 May; 124(1):27-34. PubMed ID: 9630339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of residues involved in ligand binding to the neurokinin-2 receptor.
    Huang RR; Vicario PP; Strader CD; Fong TM
    Biochemistry; 1995 Aug; 34(31):10048-55. PubMed ID: 7543277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of tachykinin receptors in the rabbit lung.
    Millard SL; Bloom JW; Yamamura HI
    Neurochem Res; 1996 Feb; 21(2):277-83. PubMed ID: 9182253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor.
    Bhogal N; Donnelly D; Findlay JB
    J Biol Chem; 1994 Nov; 269(44):27269-74. PubMed ID: 7961636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.
    Warner FJ; Miller RC; Burcher E
    Biochem Pharmacol; 2002 Jun; 63(12):2181-6. PubMed ID: 12110377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic evaluation of neurokinin-2 receptor antagonists in the guinea pig respiratory tract.
    Venugopal CS; Christopher CL; Wilson SM; Polikepahad S; Dequeant E; Holmes EP
    Am J Vet Res; 2004 Jul; 65(7):984-91. PubMed ID: 15281659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ.
    Greenfeder S; Cheewatrakoolpong B; Billah M; Egan RW; Keene E; Murgolo NJ; Anthes JC
    Bioorg Med Chem; 1999 Dec; 7(12):2867-76. PubMed ID: 10658591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a tachykinin NK(2) receptor antagonist, nepadutant, on cardiovascular and gastrointestinal function in rats and dogs.
    Giuliani S; Guelfi M; Toulouse M; Buéno L; Lecci A; Tramontana M; Criscuoli M; Maggi CA
    Eur J Pharmacol; 2001 Mar; 415(1):61-71. PubMed ID: 11245853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.
    Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL
    Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of Met297 in the seventh transmembrane segment of the tachykinin NK2 receptor with neurokinin A.
    Labrou NE; Bhogal N; Hurrell CR; Findlay JB
    J Biol Chem; 2001 Oct; 276(41):37944-9. PubMed ID: 11489908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
    Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
    Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.